Chemerin, an adipokine with elevated levels in obesity, type 2 diabetes, and osteoporosis patients, was found to heighten ERK5 expression, enhancing actin ring formation and bone resorption activity in mature osteoclasts, without impacting osteoclast differentiation and formation [178]. The gene discussed is MAPK7; the disease is osteoporosis.